Kinetix

Kinetix Networks Chooses IP Infusion For Disaggregated Network Buildout

Retrieved on: 
Wednesday, October 18, 2023
Data Management, Technology, Telecommunications, Mobile, Wireless, Software, Networks, Hardware, Data-rate units, Kinetix, Mobile phone, Cryptocurrency

IP Infusion , the market leader in carrier-grade networking software systems, announced today that Australian Internet Service Provider Kinetix Networks has implemented IP Infusion OcNOS® software and hardware from UfiSpace to upgrade and service their network.

Key Points: 
  • IP Infusion , the market leader in carrier-grade networking software systems, announced today that Australian Internet Service Provider Kinetix Networks has implemented IP Infusion OcNOS® software and hardware from UfiSpace to upgrade and service their network.
  • Kinetix is using OcNOS to connect Layer 2 networking partners directly.
  • OcNOS also serves as an underlay platform to provide the upstream connection to Australia’s National Broadband Network.
  • Cost and availability of products allowed Kinetix to deploy redundancy to mitigate any potential service interruptions.

GENIXUS Announces Launch of KinetiXTM Rocuronium Bromide Injection 5mL & 10mL Ready-to-Administer Syringes

Retrieved on: 
Thursday, August 3, 2023
Medical Supplies, FDA, Hospitals, Clinical Trials, Biotechnology, Other Health, Managed Care, Health, Pharmaceutical, Hypersensitivity, Patient, Neuromuscular blocking agents, Kinetix, ECG, Rocuronium bromide, Multimedia, Chronic pain, Cosmetic, CCO, QT interval, Paralysis, Federal Food, Drug, and Cosmetic Act, Anaphylaxis, Valvular heart disease, Propofol, Hubli railway division, Nursing care plan, Relaxation, Pulmonary hypertension, Syringe, FD, Consciousness, Pfizer, Pharmaceutical industry, Nursing

View the full release here: https://www.businesswire.com/news/home/20230803139911/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230803139911/en/
    KinetiX Propofol & Rocuronium Bromide Injection RTA Syringes.
  • KinetiX Rocuronium Bromide Injection possesses several key attributes inherent in the KinetiX platform:
    GENIXUS' Chief Commercial Officer (CCO), Seth Coombs , emphasized the company's determination to accelerate the launch of Rocuronium Bromide Injection to address the ongoing, and expected worsening, of shortages in the US market.
  • If rocuronium bromide injection is administered via the same infusion line that is also used for other drugs, it is important that this infusion line is adequately flushed between administration of rocuronium bromide injection and drugs for which incompatibility with rocuronium bromide injection has been demonstrated or for which compatibility with rocuronium bromide injection has not been established.
  • Rocuronium bromide is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents.

SkyKick Releases Major Platform Upgrades with New Intelligent Cloud Backup Product, Revamped Security Manager, and Next-Generation Migration Suites

Retrieved on: 
Thursday, July 27, 2023
Internet, Security, Data Management, Technology, Software, Cloud, ISO, Microsoft Planner, Microsoft, Internet Group Management Protocol with Access Control, Dimension Data Pro-Am, MSP, PCI, SMB, Automation, Kinetix, ITIL security management, AI, Remote backup service, ITSP, Video game, Cryptocurrency

SkyKick ( https://www.skykick.com ), a global leader in cloud automation and management solutions for information technology service providers (ITSPs), today announced major enhancements to its Cloud Management Platform.

Key Points: 
  • SkyKick ( https://www.skykick.com ), a global leader in cloud automation and management solutions for information technology service providers (ITSPs), today announced major enhancements to its Cloud Management Platform.
  • “As pioneers in Microsoft 365 cloud data protection and security, we closely monitor usage and adoption trends among customers and partners," said SkyKick Co-CEO Todd Schwartz.
  • SkyKick is announcing a reimagined Cloud Backup product, offering Intelligent Data Protection for Microsoft 365.
  • We created Security Manager to help partners be more proactive on security and grow a stronger practice,” said SkyKick Co-CEO Evan Richman.

MetricStream and Kinetix Partnership Enables Customers to Automatically Identify Regulatory Obligations and Accelerate Regulatory Change Compliance

Retrieved on: 
Wednesday, March 29, 2023
Software, Networks, Internet, Artificial Intelligence, Data Management, Professional Services, Technology, Security, Organization, Automation, AI, Partnership, Senior, GRC, IRM, Risk, Medical device, Kinetix

This new partnership will provide compliance teams with automated, AI-powered identification, extraction, and review of regulatory obligations that specifically apply to their organizations.

Key Points: 
  • This new partnership will provide compliance teams with automated, AI-powered identification, extraction, and review of regulatory obligations that specifically apply to their organizations.
  • It will enable businesses to accelerate alignment with relevant regulatory requirements and ensure timely and accurate compliance.
  • “With this advanced technology, customers can streamline extracting and capturing regulatory updates, parsing regulatory obligations, and mapping requirements to policies.
  • We are proud to partner with MetricStream to bring this innovative technology to the market and empower customers to implement efficient and effective regulatory compliance programs.”
    MetricStream’s AI-Powered Regulatory Compliance software enables customers to run efficient and effective compliance programs.

MetricStream and Kinetix Partnership Enables Customers to Automatically Identify Regulatory Obligations and Accelerate Regulatory Change Compliance

Retrieved on: 
Wednesday, March 29, 2023
Professional Services, Data Management, Technology, Software, Finance, Fintech, Artificial Intelligence, Organization, Automation, AI, Partnership, Senior, GRC, IRM, Risk, Medical device, Kinetix

This new partnership will provide compliance teams with automated, AI-powered identification, extraction, and review of regulatory obligations that specifically apply to their organizations.

Key Points: 
  • This new partnership will provide compliance teams with automated, AI-powered identification, extraction, and review of regulatory obligations that specifically apply to their organizations.
  • It will enable businesses to accelerate alignment with relevant regulatory requirements and ensure timely and accurate compliance.
  • “With this advanced technology, customers can streamline extracting and capturing regulatory updates, parsing regulatory obligations, and mapping requirements to policies.
  • We are proud to partner with MetricStream to bring this innovative technology to the market and empower customers to implement efficient and effective regulatory compliance programs.”
    MetricStream’s AI-Powered Regulatory Compliance software enables customers to run efficient and effective compliance programs.

Genixus™ Expands Manufacturing Capacity to Meet Demand for KinetiX™ RTA Syringes

Retrieved on: 
Tuesday, March 7, 2023
Medical Supplies, Biotechnology, Managed Care, Health, General Health, Pharmaceutical, Other Science, Medical Devices, Research, Hospitals, Science, Joint, Workflow, Joint Commission, Nursing care plan, Kinetix, Syringe, RTA, Propofol, Pharmaceutical industry, Concord

The added manufacturing capacity is in response to the marketplace demand for ready-to-administer (RTA) syringes.

Key Points: 
  • The added manufacturing capacity is in response to the marketplace demand for ready-to-administer (RTA) syringes.
  • Production of the company’s first product, KinetiX™ RTA Propofol, began at the company’s headquarters in Kannapolis and will expand into the new Concord facility.
  • ft. expansion follows on the heels of delivering the company’s first product: KinetiX RTA Propofol, available in 10ml and 20ml sizes.
  • Genixus designed the new KinetiX Propofol RTA syringe to simplify workflow and support effective care delivery.

United Safety Acquires Allsalt Maritime

Retrieved on: 
Tuesday, January 3, 2023
Ambulance, Royal Navy, Engineering, Vibration, Atmosphere, Mining, United States Department of the Navy, Shock, Forestry, Safety, Nike Shox, Death, Virus, Government, Science, Bacteria, Acquisition, Record, Medical device, Shipbuilding, Risk management, Transport, Kinetix

EXTON, Pa., Jan. 3, 2023 /PRNewswire/ -- United Safety, a global manufacturer of safety and survivability technology solutions, announced the acquisition of Allsalt Maritime closing on December 31st, 2022.

Key Points: 
  • EXTON, Pa., Jan. 3, 2023 /PRNewswire/ -- United Safety, a global manufacturer of safety and survivability technology solutions, announced the acquisition of Allsalt Maritime closing on December 31st, 2022.
  • Joseph Mirabile, CEO & President of United Safety states, "the acquisition of Allsalt Maritime is one that has been in consideration for the better part of a decade, and I'm thrilled to welcome them to the United Safety family.
  • Allsalt Maritime will join Fireboy® - Xintex® as United Safety continues to grow its product offerings in the marine space.
  • United Safety and Survivability Corporation is committed to delivering the most innovative and reliable safety and survivability solutions that our customers can trust to protect life and property.

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

Retrieved on: 
Wednesday, August 31, 2022
Pharmaceutical, General Health, Health, FDA, Artificial Intelligence, Technology, Supply Chain Management, Retail, Medication, Doctor of Pharmacy, Solution, RTA, LinkedIn, Propofol, Senior, NDC, RFID, Hospital, Refrigeration, Kinetix, FDA, Syringe, Patient, Medicine, Medical device

Medications labeled with RFID tags at the manufacturer level helps ensure item-level visibility of drug products throughout their dynamic lifecycle.

Key Points: 
  • Medications labeled with RFID tags at the manufacturer level helps ensure item-level visibility of drug products throughout their dynamic lifecycle.
  • As a result, there are a variety of favorable outcomes including notably heightened workflow efficiency, decreased spending and streamlined inventory for hospitals.
  • RFID tags record data for each dose such as lot number, national drug code (NDC), and refrigeration date.
  • To date, our more than 1,000 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems.

Genixus™ Introduces Propofol as the First Product to be Delivered Within KinetiX™ Ready-to-Administer (RTA) Syringe Platform

Retrieved on: 
Tuesday, August 9, 2022
Workflow, OR, Conference, RTA, Kinetix, Bedside, Medicine, Propofol

LAS VEGAS, Aug. 9, 2022 /PRNewswire/ -- Genixus™, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it will offer Propofol as the first product within its KinetiX™ platform of RTA syringe products at the Annual National Pharmacy Purchasing Association Conference (booth # 603-605). 

Key Points: 
  • "Following the recent 503B registration and licensing of our facility in North Carolina, Genixus is excited to deliver an RTA format of Propofol, one of the most commonly used medications within the OR setting" said Seth Coombs , Co-Founder & Chief Commercial Officer of Genixus.
  • "Our KinetiX platform is designed to deliver clinical tools that seamlessly integrate intothe operations of the acute and critical care setting, allowing clinicians to focus on their ultimate goal: the quality of care and patient outcomes."
  • The new Propofol Syringe is the first product to be available within the KinetiX RTA platform, which is designed to simplify workflow and support effective care delivery.
  • To support error resistance and clinical efficiency, KinetiX Propofol features several key attributes:

Genixus Receives Federal Registration & State Licensing to Begin Production of KinetiX™ Ready-to-Administer (RTA) Syringe Platform for Acute and Critical Care Medicines

Retrieved on: 
Wednesday, August 3, 2022
Patient, Evolutionary models of human drug use, Multimedia, Kinetix, Syringe, FDA, LinkedIn, Solution, Entrepreneurship, Hospital, FD, View, Acceleration, CGMP, Medicine

KANNAPOLIS, N.C., Aug. 3, 2022 /PRNewswire/ -- Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it has received both federal registration and state licensing to begin commercial production of its new KinetiX™ RTA Platform brand of pre-filled syringes. The company recently received federal 503B and Repackaging registration from the U.S. Food & Drug Administration under the Human Drug Outsourcing Facilities of the FD&C Act and Current Good Manufacturing Practices (CGMP), in addition to North Carolina Drug Manufacturing and Repackaging licensure.

Key Points: 
  • KANNAPOLIS, N.C., Aug. 3, 2022 /PRNewswire/ -- Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it has received both federal registration and state licensing to begin commercial production of its new KinetiX RTA Platform brand of pre-filled syringes.
  • The federal registration and state licensing at its state-of-the-art facility in Kannapolis, NC will enable Genixus to initiate commercialization of the KinetiX RTA Platform of pre-filled syringe medications beginning later this year.
  • Driven by quality, simplicity, and transparency, the KinetiX RTA Platform is designed to deliver clinical tools that seamlessly integrate into the acute and critical care setting.
  • Genixus is a development stage pharmaceutical manufacturer and FDA-registered outsourcing provider of high-quality easy-to-use ready-to-administer products for the acute and critical care setting.